The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders
- PMID: 37229916
- DOI: 10.1016/j.psyneuen.2023.106295
The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders
Abstract
Among the sources of chemical signals regulating food intake, energy metabolism and body weight, few have attracted recently as much attention as the expanded endocannabinoid system, or endocannabinoidome (eCBome), and the gut microbiome, the two systems on which this review article is focussed. Therefore, it is legitimate to expect that these two systems also play a major role in the etiopathology of eating disorders (EDs), in particular of anorexia nervosa, bulimia nervosa and binge-eating disorder. The major mechanisms through which, also via interactions with other endogenous signaling systems, the eCBome, with its several lipid mediators and receptors, and the gut microbiome, via its variety of microbial kingdoms, phyla and species, and armamentarium of metabolites, intervene in these disorders, are described here, based on several published studies in either experimental models or patients. Additionally, in view of the emerging multi-faceted cross-talk mechanisms between these two complex systems, we discuss the possibility that the eCBome-gut microbiome axis is also involved in EDs.
Keywords: Anorexia nervosa; Binge-eating disorder; Cannabinoid; Endocannabinoid; Endocannabinoidome; Microbiota; Vanilloid.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflict of interest regarding the article entitled “The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders/ by H.-D. Mir and colleagues.
Similar articles
-
The Role of the Gut Microbiome, Immunity, and Neuroinflammation in the Pathophysiology of Eating Disorders.Nutrients. 2021 Feb 3;13(2):500. doi: 10.3390/nu13020500. Nutrients. 2021. PMID: 33546416 Free PMC article. Review.
-
A systematic review on the role of microbiota in the pathogenesis and treatment of eating disorders.Eur Psychiatry. 2020 Dec 16;64(1):e2. doi: 10.1192/j.eurpsy.2020.109. Eur Psychiatry. 2020. PMID: 33416044 Free PMC article.
-
Role of the Endocannabinoidome in Human and Mouse Atherosclerosis.Curr Pharm Des. 2019;25(29):3147-3164. doi: 10.2174/1381612825666190826162735. Curr Pharm Des. 2019. PMID: 31448709 Review.
-
The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders .Dialogues Clin Neurosci. 2020 Sep;22(3):259-269. doi: 10.31887/DCNS.2020.22.3/vdimarzo. Dialogues Clin Neurosci. 2020. PMID: 33162769 Free PMC article. Review.
-
The role of the intestinal microbiota in eating disorders - bulimia nervosa and binge eating disorder.Psychiatry Res. 2021 Jun;300:113923. doi: 10.1016/j.psychres.2021.113923. Epub 2021 Apr 4. Psychiatry Res. 2021. PMID: 33857846 Review.
Cited by
-
Relationship of Genetic Polymorphisms and Microbial Composition with Binge Eating Disorder: A Systematic Review.Healthcare (Basel). 2024 Jul 19;12(14):1441. doi: 10.3390/healthcare12141441. Healthcare (Basel). 2024. PMID: 39057584 Free PMC article. Review.
-
Psychobiotics and the Microbiota-Gut-Brain Axis: Where Do We Go from Here?Microorganisms. 2024 Mar 22;12(4):634. doi: 10.3390/microorganisms12040634. Microorganisms. 2024. PMID: 38674579 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical